SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-010111
Filing Date
2023-03-28
Accepted
2023-03-28 07:04:08
Documents
13
Period of Report
2023-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gls-20230328.htm   iXBRL 8-K 57021
2 EX-99.1 gls-ex99_1.htm EX-99 410432
  Complete submission text file 0000950170-23-010111.txt   612142

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20230328.xsd EX-101.SCH 2460
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20230328_lab.xml EX-101.LAB 13904
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20230328_pre.xml EX-101.PRE 10225
7 EXTRACTED XBRL INSTANCE DOCUMENT gls-20230328_htm.xml XML 4881
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 23766119
SIC: 2834 Pharmaceutical Preparations